Terms: = Cervical cancer AND KDM5C, XE169, SMCX, JARID1C, 8242, ENSG00000126012, DXS1272E, MRXSJ, MRXJ, RP11-258C19_2 AND Treatment
11190 results:
1. cancer incidence, treatment, and survival in the prison population compared with the general population in England: a population-based, matched cohort study.
Lüchtenborg M; Huynh J; Armes J; Plugge E; Hunter RM; Visser R; Taylor RM; Davies EA
Lancet Oncol; 2024 May; 25(5):553-562. PubMed ID: 38697154
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
Zhou Y; Wang W; Tang J; Hu K; Zhang F
BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
[TBL] [Abstract] [Full Text] [Related]
3. Identification and Quantification of Radiotherapy-related Protein Expression in cancer Tissues Using the Qupath Software and Prediction of treatment Response.
Hasegawa T; Someya M; Tsuchiya T; Kitagawa M; Fukushima Y; Gocho T; Mafune S; Okuda R; Kaguchi J; Ohguro A; Kamiyama R; Ashina A; Toshima Y; Hirohashi Y; Torigoe T; Sakata KI
In Vivo; 2024; 38(3):1470-1476. PubMed ID: 38688633
[TBL] [Abstract] [Full Text] [Related]
4. Radiotherapy for patients with esophageal cancer aged 80 years or older: A 16-year experience.
Zhai T; Huang R; Zhan Y; Xu L; Yu Y; Guo L; Chen J; Su C; Chen C
J Cancer Res Ther; 2024 Apr; 20(2):678-683. PubMed ID: 38687940
[TBL] [Abstract] [Full Text] [Related]
5. [Effect of COVID-19 pandemics in treatment of cervical cancer: pre/post study].
Arrossi S; Binder F; Ituarte C; Martiarena N; Campanera A; Bárcena M; Paolino M
Medicina (B Aires); 2024; 84(2):236-248. PubMed ID: 38683508
[TBL] [Abstract] [Full Text] [Related]
6. A Comparative Study of Clinical Outcomes in Locally Advanced cervical cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A Tertiary Care Center Randomized Controlled Trial in India.
Alim S; Siddiqui SA; Akram M; Hakim S; Khan MA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1333-1338. PubMed ID: 38679994
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Significance of Serum SCC Levels Before treatment for Locally Advanced cervical Squamous Cell Carcinoma.
Yamaoka Y; Tamura S; Yamanoi K; Taki M; Murakami R; Yamaguchi K; Hamanishi J; Mandai M
Anticancer Res; 2024 May; 44(5):2009-2019. PubMed ID: 38677756
[TBL] [Abstract] [Full Text] [Related]
8. Reproductive Outcomes in Young Women with Early-Stage cervical cancer Greater than 2 cm Undergoing Fertility-Sparing treatment: A Systematic Review.
D'Amato A; Riemma G; Agrifoglio V; Chiantera V; Laganà AS; Mikuš M; Dellino M; Maglione A; Faioli R; Giannini A; Trojano G; Etrusco A
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674254
[No Abstract] [Full Text] [Related]
9. Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in cervical cancer Cells.
Mehta H; Ambele MA; Mokgautsi N; Moela P
Cells; 2024 Apr; 13(8):. PubMed ID: 38667315
[TBL] [Abstract] [Full Text] [Related]
10. Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancer.
Eiro N; Fraile M; Escudero-Cernuda S; Sendon-Lago J; Gonzalez LO; Fernandez-Sánchez ML; Vizoso FJ
Stem Cell Res Ther; 2024 Apr; 15(1):121. PubMed ID: 38664697
[TBL] [Abstract] [Full Text] [Related]
11. Phytosynthesis of silver nanoparticles using aqueous sandalwood (Santalum album L.) leaf extract: Divergent effects of SW-AgNPs on proliferating plant and cancer cells.
Gowda A; T C S; Anil VS; Raghavan S
PLoS One; 2024; 19(4):e0300115. PubMed ID: 38662724
[TBL] [Abstract] [Full Text] [Related]
12. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
13. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
[No Abstract] [Full Text] [Related]
14. Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.
Fackler MJ; Pleas M; Li Y; Soni A; Xing D; Cope L; Ali S; Van Le Q; Van Nguyen C; Pham HT; Duong LM; Vanden Berg E; Wadee R; Michelow P; Chen WC; Joffe M; Fjeldbo CS; Lyng H; Sukumar S
Clin Epigenetics; 2024 Apr; 16(1):56. PubMed ID: 38643219
[TBL] [Abstract] [Full Text] [Related]
15. Sarcoma of the uterine cervix: experience of a single center.
Yuan H; Li L; Li N; Yao H
World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
[TBL] [Abstract] [Full Text] [Related]
16.
Abdul-Latif M; Chowdhury A; Tharmalingam H; Taylor NJ; Lakhani A; Padhani A; Hoskin P; Tsang Y
BMJ Open; 2024 Apr; 14(4):e077390. PubMed ID: 38637128
[TBL] [Abstract] [Full Text] [Related]
17. Pelvic target volume inter-fractional motion during radiotherapy for cervical cancer with daily iterative cone beam computed tomography.
Zeng Z; Zhu J; Wang Z; Wang G; Yan J; Zhang F
Radiat Oncol; 2024 Apr; 19(1):48. PubMed ID: 38622628
[TBL] [Abstract] [Full Text] [Related]
18. Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial.
Oaknin A; Moore K; Meyer T; López-Picazo González J; Devriese LA; Amin A; Lao CD; Boni V; Sharfman WH; Park JC; Tahara M; Topalian SL; Magallanes M; Molina Alavez A; Khan TA; Copigneaux C; Lee M; Garnett-Benson C; Wang X; Naumann RW
Lancet Oncol; 2024 May; 25(5):588-602. PubMed ID: 38608691
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.
Choi CH; Lee JW; Bae DS; Kang ES; Cho D; Kim YM; Kim K; Kim JW; Kim HS; Kim YT; Lee JY; Lim MC; Oh T; Song B; Jeon I; Park M; Kim WH; Kang CY; Kim BG
Front Immunol; 2024; 15():1371353. PubMed ID: 38605958
[TBL] [Abstract] [Full Text] [Related]
20. Baseline knowledge on risk factors, symptoms and intended behavior of women and men towards screening and treatment of cervical cancer in rural Uganda: a cross-sectional study.
Nakisige C; de Fouw M; Nakalembe M; Orem J; Atukonyera D; Musheshe M; Koot J; de Zeeuw J; Beltman J; Stekelenburg J
BMC Cancer; 2024 Apr; 24(1):450. PubMed ID: 38605317
[TBL] [Abstract] [Full Text] [Related]
[Next]